What are the treatment options for resistant Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria?

Expert Opin Pharmacother. 2020 Oct;21(15):1781-1787. doi: 10.1080/14656566.2020.1779221. Epub 2020 Jun 17.

Authors

Martina Spaziante¹, Alessandra Oliva^{1

2}, Giancarlo Ceccarelli¹, Mario Venditti¹

Affiliations

¹ Department of Public Health and Infectious Diseases, "Sapienza" University of Rome , Rome, Italy.
² IRCCS INM Neuromed , Pozzilli, Italy.

PMID: 32552181
DOI: 10.1080/14656566.2020.1779221

No abstract available

Keywords: Klebsiella pneumoniae carbapenemase; Antimicrobial stewardship; gram-negative infections; multidrug resistance.

Publication types

Editorial